2Halvorsen S, kjonsberg Oh, Godd HC, The stimulatory effect of soluble fibrin on plasminogen activation by tissue plasminogen actrvator. Thromb Res, 1991;61 : 453.
3Inoue A, Koh CS, Shinada K, et al. Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Iewis rats. J Immunol, 1996;71 : 131.
4Okayama H, Hosomi N, Takahashi T, et al.Thrombin inhibiton atten-uates neurodegeneration and cerebral edema formation following transiet forebrain ischemia . Brain Res,2001;902(2): 264.
5Reimann PU, Ovase R, Weigel PH, et al .Mechanisms of cell death in primary cotical neuronsand PC12 ceils. J Neurosci Res ,2001;64(6): 654.
6Suo Z, Wu M, Ameenuddin S, et al. Participation of protease-activated receptor-1 in thrombin -induced microglial activation. J Neurochem, 2002;80 (40) :655.
7Wang H, Ubl JJ, Reiser G. Four types of protease- activated receptors, co-expressed in rat astrocyes, evoke different physiological signaling. Glia, 2002; 37(1): 53.
8Urabe Y, Tanaka R, Noda K, et al. Anticoagulant therapy with a selective turombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy . J Throm Thrombolysis, 2002;13(3): 155.
9Morris DC, Zhang LM, Zhang ZG, et al. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatro an in a rat model of embolic. Stroke, 2001;32(11) :2635.
9Bamford J,Sandercock P,Dennis M,et al.Classification and natural history of clinically identifiable subtypes of cerebral infarction[J].Lancet,1991,337(8756):1521-6.
10Klocking HP,Hoffmann A,Markwardt F.Release of plasminogen activator by batroxobin[J].Haemostasis,1997,17(8):235-9.
